Hello, I'm Martin
I help Biotechs, Pharmas, and CROs navigate the complexity of musculoskeletal endpoints in nonclinical development.
​
With more than 20 years of dedicated experience in musculoskeletal research, I support clients in addressing challenges where the musculoskeletal system is either the primary therapeutic target or a critical safety concern. My expertise spans study design, endpoint selection, data interpretation, and scientific strategy across preclinical research and toxicology programs.
​
My scientific journey began at the École Nationale Vétérinaire de Toulouse (France), where I earned my Doctorate of Veterinary Medicine (DVM) and completed a thesis focused on anterior cruciate ligament (ACLT) surgery in dogs. I then pursued advanced academic research in musculoskeletal biology and pharmacology. During my M.Sc. in Veterinary Sciences (Toxicology), I investigated tetracycline-induced bone toxicity in pigs using bone densitometry. My Ph.D. in Veterinary Sciences (Pharmacology) focused on osteoarthritis-related pain in cats, leading to some of the earliest characterizations of the condition and the evaluation of potential therapeutic approaches. Throughout this period, I also contributed to collaborative research on osteoarthritis-related pain in dogs and rodent models.
​
Following my academic career, I spent 11 years at Charles River Laboratories in Montreal, where I served as a Individual Scientist and Principal Investigator supporting musculoskeletal research and toxicology programs. My work involved the interpretation of data from radiology, bone densitometry, imaging, biomechanics, and bone biomarkers across a wide range of studies, including osteoporosis research and safety evaluations. During my final four years, I served as the Global Subject Matter Expert in musculoskeletal toxicology and Scientific Lead for the Musculoskeletal and Imaging Group.
​
​
Let's work together to accelerate your preclinical pipeline with scientific rigor and specialized expertise in musculoskeletal research.